Super Salmon!

Pharmaceutical Pollution Is Shifting the Balance of Ocean Ecosystems

April 15, 2025 Written by Matthew Russell

In rivers and oceans across the globe, fish are behaving strangely. Some swim faster than they should. Others take risks they’d normally avoid. Many abandon the social structures that once protected them. These shifts are not random. They point to an invisible threat flowing just beneath the surface: pharmaceutical pollution.

Drugs designed for human anxiety, pain, and insomnia are entering the world’s water systems through sewage, manufacturing waste, and improper disposal. Once there, they don’t vanish. They linger, affect wildlife, and disrupt entire ecosystems.

Bold Fish, Bigger Risks

Juvenile salmon migrating from Sweden’s River Dal to the Baltic Sea have become an unexpected case study. Researchers implanted hundreds of these fish with tiny slow-release doses of clobazam, an anti-anxiety drug commonly prescribed to humans. Tracking tags revealed something remarkable: salmon exposed to the drug completed their journey faster and in greater numbers than their drug-free peers.

According to Jack Brand, a researcher at the Swedish University of Agricultural Sciences, these medicated salmon passed through hydropower dams two to three times faster than untreated fish, likely because they were less hesitant around the turbines, NPR reports.

This boldness might sound like a survival advantage. But in ecosystems, risk-taking has consequences. When predators lurk or conditions shift, impulsive behavior can turn deadly.

Anti-anxiety drugs are altering fish behavior in the wild.

A Global Cocktail of Contaminants

The scope of contamination is staggering. Almost 1,000 pharmaceutical compounds have been detected in waterways around the world—including Antarctica. A Cary Institute report found that up to 80% of streams in the U.S. alone are polluted with pharmaceuticals and personal care products.

These compounds are potent by design. Many target receptors in the human brain, and those same receptors are found in fish and other species. Drugs like benzodiazepines, used to treat anxiety in people, also alter the stress response in fish. As a result, animals become less risk-averse, change their migration timing, or fail to form protective schools—shifts that can affect survival.

Drugged salmon are taking dangerous risks during migration.

From Lab to Wild

Previous experiments hinted at these effects. In labs, fish exposed to psychoactive drugs became more isolated and less cautious. But the new field studies from Sweden show that these behavioral changes persist—and even intensify—in the wild.

A follow-up experiment revealed that drugged salmon formed looser groups, even when a predator was nearby. The tighter a school, the safer its members. Disrupted shoaling behavior means more fish swimming solo—making them easier prey.

Michael Bertram, an ecologist leading the study, described the salmon’s altered behavior as a form of “unnatural selection,” The New York Times reports. If bolder fish survive migration but die later in predator-rich waters, the long-term outcome could be population decline, not resilience.

Predator-prey dynamics are being disrupted by pharmaceutical waste.

The Long Tail of Human Medicine

Human waste isn’t the only path these drugs take to the water. Wastewater from hospitals, improper drug disposal, and runoff from pharmaceutical manufacturing sites all contribute. Deutsche Welle reports that some wastewater treatment plants near manufacturing facilities have drug levels 1,000 times higher than others.

Yet most treatment plants are not equipped to filter out pharmaceuticals. Some drugs pass through the system unchanged. Others break into byproducts that are just as toxic.

Unknowns Beneath the Surface

Despite years of research, the full ecological impact of pharmaceutical pollution is unknown. Scientists have documented effects on hundreds of species, including reproductive issues and behavioral disruptions. A Cary Institute investigation described how certain antidepressants alter fish breeding cycles, while hormones from birth control pills can cause male fish to develop female egg cells.

As compounds accumulate in fish, they climb up the food chain. Birds, mammals, and even humans may be exposed through drinking water or consumption of contaminated seafood.

Solutions and Setbacks

There are potential fixes. Advanced treatment technologies like ozonation and membrane filtration can help. But they’re expensive and rare. Designing drugs that biodegrade safely—an approach known as green chemistry—is promising, though slow to implement.

Policy change is another lever. Currently, pharmaceutical companies are responsible for testing their own products for environmental safety. Critics argue that these reviews are insufficient and underregulated.

Improved drug disposal practices, public education, and cross-agency coordination could all make a difference. But as things stand, no pharmaceuticals are currently regulated under the EPA’s primary drinking water standards, Cary Institute reports.

The Cost of Inaction

The salmon darting through Swedish dams may seem like a scientific curiosity. But they are just one visible indicator of a much larger, invisible crisis. Every flushed pill, every untreated discharge, adds to a global experiment with no control group and no reset button.

What happens in rivers doesn’t stay there. It shapes the ocean, the land, and the web of life that connects them all.

Click and help us keep our oceans clean! (Note from A: this is a simple free Greater Good organization click-to-donate; the easily ignored ads help pay for cleaning the ocean. I’ll never know whether you click or not, I just wanted to let you know what it is.)

More Science!

Bright future for medicines and farming after fluorine discovery

July 30, 2024 Ellen Phiddian

US researchers have figured out an environmentally friendly way to mix fluorine into carbon molecules using enzymes and light.

The discovery illuminates a path for safer and more ecologically sound materials, particularly pharmaceuticals and agricultural chemicals.

“This work could pave the way for new, greener technologies in chemical production,” says senior researcher Professor Huimin Zhao, from the University of Illinois at Urbana-Champaign.

The discovery is published in Science.

Fluorine atoms can be very powerful additions to bioactive materials. They can make medicines easier to absorb, more stable in biological systems, and better at interacting with other proteins. About 20% of pharmaceuticals on the market contain fluorine.

But these organic (carbon-containing) molecules all typically need a bond between a fluorine atom and a carbon atom to work.

This bond is rare in nature, and difficult to make in a lab. At the moment, most fluorine-containing substances are made using super-toxic hydrogen fluoride, which can be fatal with just a small splash to the skin.

This has spurred chemists to hunt for other ways to fluorinate molecules.

In this research, the scientists used a protein that responds to light, called a photoenzyme.

Using this enzyme, they were able to add fluorine to a class of molecules called olefins. These carbon-containing molecules are widely used as a feedstock in the chemical industry, because they’re easy to turn into a range of other molecules.

The reaction is also “stereoselective”: it can differentiate between molecules that are chemically identical, but optically different. This is a difficult property to achieve in a lab, but crucial to the pharmaceutical and agricultural market because biological organisms can react differently to optically different molecules.

Two people smiling in lab
Maolin Li (seated) and Huimin Zhao in the lab. Credit: Center for Advanced Bioenergy and Bioproducts Innovation (CABBI)

“Our research opens up fascinating possibilities for the future of pharmaceutical and agrochemical development,” says Dr Maolin Li, a postdoctoral researcher at the University of Illinois at Urbana-Champaign.

“By integrating fluorine into organic molecules through a photoenzymatic process, we are not only enhancing the beneficial properties of these compounds but also doing so in a manner that’s more environmentally responsible.

“It’s thrilling to think about the potential applications of our work in creating more effective and sustainable products for everyday use.”

https://cosmosmagazine.com/science/chemistry/fluorine-addition-pharmaceuticals/